You just read:

Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biopsy Test at the 17th IASLC World Conference on Lung Cancer

News provided by

Biocept, Inc.

07 Dec, 2016, 09:45 ET